Cargando…
30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study
BACKGROUND: 30-day mortality might be a useful indicator of avoidable harm to patients from systemic anticancer treatments, but data for this indicator are limited. The Systemic Anti-Cancer Therapy (SACT) dataset collated by Public Health England allows the assessment of factors affecting 30-day mor...
Autores principales: | Wallington, Michael, Saxon, Emma B, Bomb, Martine, Smittenaar, Rebecca, Wickenden, Matthew, McPhail, Sean, Rashbass, Jem, Chao, David, Dewar, John, Talbot, Denis, Peake, Michael, Perren, Timothy, Wilson, Charles, Dodwell, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Pub. Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027226/ https://www.ncbi.nlm.nih.gov/pubmed/27599138 http://dx.doi.org/10.1016/S1470-2045(16)30383-7 |
Ejemplares similares
-
Data Resource Profile: The Systemic Anti-Cancer Therapy (SACT) dataset
por: Bright, Chloe J, et al.
Publicado: (2020) -
Corrigendum to: Data Resource Profile: The Systemic Anti-Cancer Therapy (SACT) Dataset
por: Bright, Chloe J, et al.
Publicado: (2020) -
Stage at diagnosis and early mortality from cancer in England
por: McPhail, S, et al.
Publicado: (2015) -
Sociodemographic variation in the use of chemotherapy and radiotherapy in patients with stage IV lung, oesophageal, stomach and pancreatic cancer: evidence from population-based data in England during 2013–2014
por: Henson, Katherine E, et al.
Publicado: (2018) -
Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit
por: Swann, Ruth, et al.
Publicado: (2018)